ARISTADA
NDC 65757-402, aripiprazole lauroxil, injection, suspension, extended release, from Alkermes, Inc..
- Product NDC
- 65757-402
- Status
- Listed
- Labeler
- Alkermes, Inc.
- Dosage form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA207533
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65757-402 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ARIPIPRAZOLE LAUROXIL662 mg/2.4mL
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65757-402-03 | 65757040203 | 1 SYRINGE in 1 CARTON (65757-402-03) / 2.4 mL in 1 SYRINGE |
| 65757-402-04 | 65757040204 | 1 SYRINGE in 1 CARTON (65757-402-04) / 2.4 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/17a8d11b-73b0-4833-a0b4-cf1ef85edefbMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=65757-402NADAC price for package 65757040203
GET /v1/drugs/nadac/65757040203
Use it
Look up 65757-402 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65757-402 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65757-402. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.